GEN vs MREO · P/E 17, rev $5.00B vs $48.7M cap
Gen Digital Inc. (GEN) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. MREO currently screens at market cap $48.7M.
Not investment advice. Open the GEN and MREO stock pages for the full models.
Not investment advice.